Bahl & Gaynor’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-4,273
| Closed | -$251K | – | 422 |
|
|
2015
Q4 | $251K | Sell |
4,273
-3,136
| -42% | -$184K | ﹤0.01% | 388 |
|
|
2015
Q3 | $423K | Buy |
7,409
+1,002
| +16% | +$57.2K | 0.01% | 333 |
|
|
2015
Q2 | $578K | Buy |
6,407
+293
| +5% | +$26.4K | 0.01% | 307 |
|
|
2015
Q1 | $588K | Buy |
6,114
+4,025
| +193% | +$387K | 0.01% | 281 |
|
|
2014
Q4 | $183K | Sell |
2,089
-3,582
| -63% | -$314K | ﹤0.01% | 408 |
|
|
2014
Q3 | $519K | Buy |
5,671
+781
| +16% | +$71.5K | 0.01% | 279 |
|
|
2014
Q2 | $563K | Buy |
4,890
+10
| +0.2% | +$1.15K | 0.01% | 264 |
|
|
2014
Q1 | $591K | Buy |
4,880
+211
| +5% | +$25.6K | 0.01% | 256 |
|
|
2013
Q4 | $587K | Buy |
4,669
+376
| +9% | +$47.3K | 0.01% | 242 |
|
|
2013
Q3 | $467K | Buy |
+4,293
| New | +$467K | 0.01% | 254 |
|